Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03654716
Title Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Dana-Farber Cancer Institute
Indications

rhabdoid cancer

hepatoblastoma

retinoblastoma

lymphoma

Advanced Solid Tumor

Therapies

ALRN-6924 + Cytarabine

ALRN-6924

Age Groups: adult | child
Covered Countries USA

Additional content available in CKB BOOST